Ghana's FDA regulates medical products to ensure safety and effectiveness, requiring local representatives for market authorization.

The Public Health Act 851 of 2012 establishes a legal framework for safety monitoring. Local representatives monitor product safety and report adverse events, while the FDA analyses drug reactions.

Currently, there are no specific pharmacovigilance requirements for anti-cancer medicines, and Market Authorization Holders must appoint qualified persons for pharmacovigilance.